Edition:
India

Aradigm Corp (ARDM.OQ)

ARDM.OQ on NASDAQ Stock Exchange Capital Market

1.30USD
16 Feb 2018
Change (% chg)

$0.03 (+2.36%)
Prev Close
$1.27
Open
$1.35
Day's High
$1.35
Day's Low
$1.27
Volume
23,857
Avg. Vol
64,621
52-wk High
$7.26
52-wk Low
$0.80

Select another date:

Mon, Jan 29 2018

BRIEF-FDA Declines To Approve Aradigm's Drug Linhaliq

* ARADIGM RECEIVES COMPLETE RESPONSE LETTER FROM THE FDA FOR LINHALIQ NDA

BRIEF-Aradigm - FDA Advisory Committee Did Not Recommend Approval For Linhaliq

* ARADIGM REPORTS RESULTS OF FDA ADVISORY COMMITTEE MEETING ON LINHALIQ‍​

BRIEF-Boxer Capital Reports 5.9 Pct Passive Stake In Aradigm Corp As Of Nov 30

* BOXER CAPITAL LLC REPORTS 5.9 PERCENT PASSIVE STAKE IN ARADIGM CORP AS OF NOVEMBER 30 - SEC FILING Source text: (http://bit.ly/2BDnINX) Further company coverage:

BRIEF-Aradigm Announces FDA Advisory Committee Meeting For Linhaliq

* ARADIGM ANNOUNCES FDA ADVISORY COMMITTEE MEETING FOR LINHALIQ

BRIEF-Aradigm Corp files for common stock offering of up to $20 mln

* Aradigm Corp files for common stock offering of up to $20 million - SEC filing‍​ Source text: (http://bit.ly/2lOJdUD) Further company coverage:

BRIEF-Aradigm Q3 loss per share $0.26

* Aradigm corp - qtrly ‍rev $2.7 million versus $50,000​ Source text for Eikon: Further company coverage:

Select another date: